Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis
- 15 November 1997
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 350 (9089), 1439-1443
- https://doi.org/10.1016/s0140-6736(97)06468-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Pathophysiology, Treatment and Outcome of Meningococcemia: A Review and Recent ExperienceThe Pediatric Infectious Disease Journal, 1996
- Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing ProteinProtein Expression and Purification, 1996
- The Excessive Complement Activation in Fulminant Meningococcal Septicemia Is Predominantly Caused by Alternative Pathway ActivationThe Journal of Infectious Diseases, 1996
- Inhibition of Endotoxin-Induced Cytokine Release and Neutrophil Activation in Humans by Use of Recombinant Bactericidal/Permeability-Increasing ProteinThe Journal of Infectious Diseases, 1995
- Bactericidal/Permeability-Increasing Protein Inhibits Induction of Macrophage Nitric Oxide Production by LipopolysaccharideThe Journal of Infectious Diseases, 1994
- Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.JCI Insight, 1992
- The Cardiovascular Response of Normal Humans to the Administration of EndotoxinThe New England Journal of Medicine, 1989
- Plasma Endotoxin as a Predictor of Multiple Organ Failure and Death in Systemic Meningococcal DiseaseThe Journal of Infectious Diseases, 1989
- Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987The Pediatric Infectious Disease Journal, 1989
- The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.The Journal of Experimental Medicine, 1989